Literature DB >> 30803967

Molecular Characterization of Multidrug-Resistant Pseudomonas aeruginosa Isolates in Hospitals in Myanmar.

Tatsuya Tada1, Tomomi Hishinuma1, Shin Watanabe2, Hiroki Uchida1, Mari Tohya1, Kyoko Kuwahara-Arai1, San Mya3, Khin Nyein Zan3, Teruo Kirikae4, Htay Htay Tin3.   

Abstract

The emergence of multidrug-resistant (MDR) Pseudomonas aeruginosa has become a serious worldwide medical problem. This study was designed to clarify the genetic and epidemiological properties of MDR P. aeruginosa strains isolated from hospitals in Myanmar. Forty-five MDR P. aeruginosa isolates obtained from different patients in seven hospitals in Myanmar were screened using the broth microdilution method. The whole genomes of the MDR isolates were sequenced using a MiSeq platform (Illumina). Phylogenetic trees were constructed from single nucleotide polymorphism concatemers. Multilocus sequence types were deduced, and drug resistance genes were identified. Of the 45 isolates, 38 harbored genes encoding carbapenemases, including DIM-1, IMP-1, NDM-1, VIM-2, and VIM-5, and 9 isolates had genes encoding 16S rRNA methylases, including RmtB, RmtD3, RmtE, and RmtF2. Most MDR P. aeruginosa strains isolated in Myanmar belonged to sequence type 1047 (ST1047). This is the first molecular epidemiological analysis of MDR P. aeruginosa clinical isolates in Myanmar. These findings strongly suggest that P. aeruginosa ST1047 strains harboring carbapenemases, including DIM-, IMP-, NDM-, and VIM-type metallo-β-lactamases, have been spreading throughout medical settings in Myanmar.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  16S rRNA methylases; Pseudomonas aeruginosazzm321990; aminoglycoside-modifying enzymes; carbapenemase; molecular epidemiology

Year:  2019        PMID: 30803967      PMCID: PMC6496111          DOI: 10.1128/AAC.02397-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0.

Authors:  Stéphane Guindon; Jean-François Dufayard; Vincent Lefort; Maria Anisimova; Wim Hordijk; Olivier Gascuel
Journal:  Syst Biol       Date:  2010-03-29       Impact factor: 15.683

Review 2.  Metallo-β-lactamases: a last frontier for β-lactams?

Authors:  Giuseppe Cornaglia; Helen Giamarellou; Gian Maria Rossolini
Journal:  Lancet Infect Dis       Date:  2011-05       Impact factor: 25.071

3.  NDM-12, a novel New Delhi metallo-β-lactamase variant from a carbapenem-resistant Escherichia coli clinical isolate in Nepal.

Authors:  Tatsuya Tada; Basudha Shrestha; Tohru Miyoshi-Akiyama; Kayo Shimada; Hiroshi Ohara; Teruo Kirikae; Bharat M Pokhrel
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

4.  Identification of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from dogs with pyoderma and otitis in Korea.

Authors:  Jae-Eun Hyun; Tae-Ho Chung; Cheol-Yong Hwang
Journal:  Vet Dermatol       Date:  2018-03-25       Impact factor: 1.589

5.  IMP-43 and IMP-44 metallo-β-lactamases with increased carbapenemase activities in multidrug-resistant Pseudomonas aeruginosa.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Kayo Shimada; Masahiro Shimojima; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

Review 6.  Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: an update.

Authors:  Jun-ichi Wachino; Yoshichika Arakawa
Journal:  Drug Resist Updat       Date:  2012-06-04       Impact factor: 18.500

7.  Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.

Authors:  Carlos Juan; Laura Zamorano; Ana Mena; Sebastián Albertí; Jose Luis Pérez; Antonio Oliver
Journal:  J Antimicrob Chemother       Date:  2010-01-12       Impact factor: 5.790

Review 8.  Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.

Authors:  Duck Jin Hong; Il Kwon Bae; In-Ho Jang; Seok Hoon Jeong; Hyun-Kyung Kang; Kyungwon Lee
Journal:  Infect Chemother       Date:  2015-06-30

9.  Complete Genome Sequence of Pseudomonas aeruginosa K34-7, a Carbapenem-Resistant Isolate of the High-Risk Sequence Type 233.

Authors:  George Taiaroa; Ørjan Samuelsen; Tom Kristensen; Ole Andreas Løchen Økstad; Adam Heikal
Journal:  Microbiol Resour Announc       Date:  2018-08-02

10.  Detection of New Delhi metallo beta lactamase-1 (NDM-1) carbapenemase in Pseudomonas aeruginosa in a single centre in southern India.

Authors:  Mariappan Shanthi; Uma Sekar; Arunagiri Kamalanathan; Balaraman Sekar
Journal:  Indian J Med Res       Date:  2014-10       Impact factor: 2.375

View more
  3 in total

Review 1.  Research Updates of Plasmid-Mediated Aminoglycoside Resistance 16S rRNA Methyltransferase.

Authors:  Weiwei Yang; Fupin Hu
Journal:  Antibiotics (Basel)       Date:  2022-07-07

2.  Function Characterization of Endogenous Plasmids in Cronobacter sakazakii and Identification of p-Coumaric Acid as Plasmid-Curing Agent.

Authors:  Xuemeng Ji; Ping Lu; Yaozhong Hu; Juan Xue; Jing Wu; Bowei Zhang; Yan Zhang; Lu Dong; Huan Lv; Shuo Wang
Journal:  Front Microbiol       Date:  2021-06-25       Impact factor: 5.640

3.  High-Risk International Clones of Carbapenem-Nonsusceptible Pseudomonas aeruginosa Endemic to Indonesian Intensive Care Units: Impact of a Multifaceted Infection Control Intervention Analyzed at the Genomic Level.

Authors:  Corné H W Klaassen; Juliëtte A Severin; Andreu Coello Pelegrin; Yulia Rosa Saharman; Aurélien Griffon; Mattia Palmieri; Caroline Mirande; Anis Karuniawati; Rudyanto Sedono; Dita Aditianingsih; Wil H F Goessens; Alex van Belkum; Henri A Verbrugh
Journal:  mBio       Date:  2019-11-12       Impact factor: 7.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.